Patent classifications
A61K36/63
COMPOSITION COMPRISING HYDROXYTYROSOL AND PUNICALAGIN FOR USE IN THE TREATMENT OF DYSLIPIDEMIA
A composition containing hydroxytyrosol and punicalagin for use in the treatment of dyslipidemia in a subject in need thereof. The hydroxytyrosol may be obtained from olives. The punicalagin may be obtained from pomegranates. The concentration of hydroxytyrosol in the composition may be between 0.5% and 5% (w/w) of the total composition. The concentration of punicalagins in the composition may be between 10% and 25% (w/w) of the total composition. The composition may further contain maltodextrin, and the concentration of maltodextrin may be between 40% and 85% (w/w) of the total composition.
COMPOSITION COMPRISING HYDROXYTYROSOL AND PUNICALAGIN FOR USE IN THE TREATMENT OF DYSLIPIDEMIA
A composition containing hydroxytyrosol and punicalagin for use in the treatment of dyslipidemia in a subject in need thereof. The hydroxytyrosol may be obtained from olives. The punicalagin may be obtained from pomegranates. The concentration of hydroxytyrosol in the composition may be between 0.5% and 5% (w/w) of the total composition. The concentration of punicalagins in the composition may be between 10% and 25% (w/w) of the total composition. The composition may further contain maltodextrin, and the concentration of maltodextrin may be between 40% and 85% (w/w) of the total composition.
Compositions and methods for activating cellular signaling pathways
Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.
Compositions and methods for activating cellular signaling pathways
Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.
Compositions and methods for activating cellular signaling pathways
Compositions and methods for increasing stress response and improving health and slowing the aging process in a user. A composition includes one or more of a first group consisting of milk thistle, ashwagandha, green tea, bacopa monnieri, and turmeric. The composition includes one or more of a second group consisting of acetyl-L-carnitine, quercetin, lipoic acid, coenzyme Q10, cysteine, and grape. The composition includes one or more of a third group consisting of wasabi, theacrine, copper, nicacin, cysteine, and olive extract.
NATURAL-SUBSTANCE COMPOSITION FOR THE TOPICAL TREATMENT AND CARE OF PSORIATIC SKIN AND OTHER SKIN DISEASES
The invention relates to a composition for the topical treatment and care of psoriatic skin. It consists exclusively of natural substances and comprises at the most peanut oil, olive oil, castor oil, avocado oil, rose oil, rose hydrolate, lanolin and phytosterol in the form of a mixture of at least peanut oil, olive oil, castor oil and lanolin.
NATURAL-SUBSTANCE COMPOSITION FOR THE TOPICAL TREATMENT AND CARE OF PSORIATIC SKIN AND OTHER SKIN DISEASES
The invention relates to a composition for the topical treatment and care of psoriatic skin. It consists exclusively of natural substances and comprises at the most peanut oil, olive oil, castor oil, avocado oil, rose oil, rose hydrolate, lanolin and phytosterol in the form of a mixture of at least peanut oil, olive oil, castor oil and lanolin.
NATURAL-SUBSTANCE COMPOSITION FOR THE TOPICAL TREATMENT AND CARE OF PSORIATIC SKIN AND OTHER SKIN DISEASES
The invention relates to a composition for the topical treatment and care of psoriatic skin. It consists exclusively of natural substances and comprises at the most peanut oil, olive oil, castor oil, avocado oil, rose oil, rose hydrolate, lanolin and phytosterol in the form of a mixture of at least peanut oil, olive oil, castor oil and lanolin.
FUNCTIONAL FOOD
It is disclosed a food mixture, in particular a food mixture comprising hydroxytyrosol, oleuropein, and soluble fibres. In particular, the present invention relates to a food mixture comprising: —a fraction (a) which comprises soluble fibres; —a powdered fraction (b) which comprises at least 100 mg/kg hydroxytyrosol and at least 250 mg/kg oleuropein where said amounts refer to said powdered fraction (b). Said food mixture finds application, moreover, in the preparation of bread, pasta, and baked goods in general. The invention also describes food products which contain this mixture, a process for the preparation thereof, as well as the uses thereof in human and animal nutrition, in the treatment and in the prevention of inflammatory conditions and in the reduction of postprandial glycaemia.
BIOCONVERSION OF OLEUROPEIN
A composition contains at least one probiotic or enzyme selected from the group consisting of (i) a probiotic having β-glycosidase activity or a β-glycosidase, (ii) a probiotic having esterase activity or an esterase, (iii) a probiotic having both β-glycosidase activity and esterase activity or an enzyme having both β-glycosidase activity and esterase activity, (iv) a first probiotic having β-glycosidase activity and a second probiotic having esterase activity, (v) a probiotic having β-glycosidase activity and an esterase, (vi) a β-glycosidase and a probiotic having esterase activity and (vii) a β-glycosidase and an esterase. The at least one probiotic can form one or more of oleuropein aglycone, elenolic acid, hydroxytyrosol acetate or hydroxytyrosol from oleuropein. The composition can comprise oleuropein. The composition can be for treating or preventing impaired mobility in an older adult; stimulating bone formation and/or inhibiting bone resorption; treating or preventing synovitis in an individual in need or at risk thereof or treating or preventing articular cartilage degradation subsequent to synovitis in an individual having or recovering from synovitis; or preventing or treating cartilage breakdown.